{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T05:22:05Z","timestamp":1773120125494,"version":"3.50.1"},"reference-count":173,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["RTG 2660"],"award-info":[{"award-number":["RTG 2660"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon Europe","doi-asserted-by":"publisher","award":["953327"],"award-info":[{"award-number":["953327"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["728018"],"award-info":[{"award-number":["728018"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.neuropharm.2025.110321","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T11:22:50Z","timestamp":1737544970000},"page":"110321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Antisocial personality disorder:Failure to balance excitation\/inhibition?"],"prefix":"10.1016","volume":"268","author":[{"given":"Klaus-Peter","family":"Lesch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikita","family":"Gorbunov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neuropharm.2025.110321_bib1","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41398-022-02218-z","article-title":"From mechanisms to markers: novel noninvasive EEG proxy markers of the neural excitation and inhibition system in humans","volume":"12","author":"Ahmad","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110321_bib2","series-title":"DSM-5)","article-title":"American Psychiatric Association: diagnostic and statistical manual of mental disorders","year":"2013"},{"key":"10.1016\/j.neuropharm.2025.110321_bib3","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/mp.2010.6","article-title":"A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication","volume":"15","author":"Arcos-Burgos","year":"2010","journal-title":"Mol. Psychiatr."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110321_bib4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41398-019-0396-7","article-title":"ADGRL3 (LPHN3) variants predict substance use disorder","volume":"9","author":"Arcos-Burgos","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110321_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.clinph.2024.11.001","article-title":"EEG aperiodic dynamics from early through late childhood: associations with ADHD, cognition, and development","volume":"168","author":"Arnett","year":"2024","journal-title":"Clin. Neurophysiol."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110321_bib6","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.neuron.2009.04.027","article-title":"Instantaneous modulation of gamma oscillation frequency by balancing excitation with inhibition","volume":"62","author":"Atallah","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2025.110321_bib7","series-title":"Recent Advances in Research on Impulsivity and Impulsive Behaviors","article-title":"The genetics of externalizing problems","volume":"vol. 47","author":"Barr","year":"2019"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110321_bib8","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1601-5215.2008.00271.x","article-title":"A magnetic resonance spectroscopy study of antisocial behaviour disorder, psychopathy and violent crime among military conscripts","volume":"20","author":"Basoglu","year":"2008","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.neuropharm.2025.110321_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134615","article-title":"The cerebral cortex is a substrate of multiple interactions between GABAergic interneurons and oligodendrocyte lineage cells","volume":"715","author":"Benamer","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2025.110321_bib10","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1038\/s41467-020-18984-7","article-title":"Myelination of parvalbumin interneurons shapes the function of cortical sensory inhibitory circuits","volume":"11","author":"Benamer","year":"2020","journal-title":"Nat. Commun."},{"issue":"25","key":"10.1016\/j.neuropharm.2025.110321_bib11","doi-asserted-by":"crossref","first-page":"8574","DOI":"10.1523\/JNEUROSCI.0225-12.2012","article-title":"NMDARs mediate the role of monoamine oxidase A in pathological aggression","volume":"32","author":"Bortolato","year":"2012","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110321_bib12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00406-022-01480-y","article-title":"Elevated levels of serotonin 5-HT2A receptors in the orbitofrontal cortex of antisocial individuals","volume":"273","author":"Braccagni","year":"2023","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110321_bib13","doi-asserted-by":"crossref","first-page":"9195","DOI":"10.1038\/s41598-020-65500-4","article-title":"Measurement of excitation-inhibition ratio in autism spectrum disorder using critical brain dynamics","volume":"10","author":"Bruining","year":"2020","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110321_bib14","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1038\/s41380-020-0673-0","article-title":"Meta-analysis and systematic review of ADGRL3 (LPHN3) polymorphisms in ADHD susceptibility","volume":"26","author":"Bruxel","year":"2021","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110321_bib15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev-neuro-062111-150444","article-title":"Mechanisms of gamma oscillations","volume":"35","author":"Buzs\u00e1ki","year":"2012","journal-title":"Annu. Rev. Neurosci."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110321_bib16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.tins.2016.04.010","article-title":"GABAergic function as a limiting factor for prefrontal maturation during adolescence","volume":"39","author":"Caballero","year":"2016","journal-title":"Trends Neurosci."},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110321_bib17","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1038\/s41386-020-0709-9","article-title":"Downregulation of parvalbumin expression in the prefrontal cortex during adolescence causes enduring prefrontal disinhibition in adulthood","volume":"45","author":"Caballero","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110321_bib18","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.semcdb.2021.02.008","article-title":"Developmental regulation of excitatory-inhibitory synaptic balance in the prefrontal cortex during adolescence","volume":"118","author":"Caballero","year":"2021","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.neuropharm.2025.110321_bib19","doi-asserted-by":"crossref","unstructured":"Carter Leno V, Begum-Ali J, Goodwin A, Pasco G, Narvekar N, Pickles A, Charman T, Johnson M, Jones E, The STAARS Team. Cortical markers of excitation\/inhibition balance are associated with sensory responsivity from infancy in longitudinal cohorts enriched for autism and ADHD. Transl. Psychiatry, 2025, doi: 10.21203\/rs.3.rs-3879380\/v1.","DOI":"10.21203\/rs.3.rs-3879380\/v1"},{"key":"10.1016\/j.neuropharm.2025.110321_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2021.147440","article-title":"GABA-A receptor signaling in the anterior cingulate cortex modulates aggression and anxiety-related behaviors in socially isolated mice","volume":"1762","author":"Chaibi","year":"2021","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110321_bib21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.neuroimage.2016.11.068","article-title":"The role of myelination in measures of white matter integrity: combination of diffusion tensor imaging and two-photon microscopy of CLARITY intact brains","volume":"147","author":"Chang","year":"2017","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2025.110321_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.conb.2022.102553","article-title":"Homeostatic plasticity and excitation-inhibition balance: the good, the bad, and the ugly","volume":"75","author":"Chen","year":"2022","journal-title":"Curr. Opin. Neurobiol."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110321_bib23","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.biopsych.2006.08.024","article-title":"Amygdala and orbitofrontal reactivity to social threat in individuals with impulsive aggression","volume":"62","author":"Coccaro","year":"2007","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110321_bib24","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1192\/bjp.188.5.423","article-title":"Prevalence and correlates of personality disorder in Great Britain","volume":"188","author":"Coid","year":"2006","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110321_bib25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/JCP.0b013e31823f8770","article-title":"The psychopharmacology of aggressive behavior","volume":"32","author":"Comai","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110321_bib26","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1038\/s41467-018-04362-x","article-title":"Study of 300,486 individuals identi\ufb01es 148 independent genetic loci in\ufb02uencing general cognitive function","volume":"9","author":"Davies","year":"2018","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110321_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065566","article-title":"Cool and hot executive function impairments in violent offenders with antisocial personality disorder with and without psychopathy","volume":"8","author":"De Brito","year":"2013","journal-title":"PLoS One"},{"issue":"23","key":"10.1016\/j.neuropharm.2025.110321_bib28","doi-asserted-by":"crossref","first-page":"7886","DOI":"10.1523\/JNEUROSCI.5068-13.2014","article-title":"How local excitation-inhibition ratio impacts the whole brain dynamics","volume":"34","author":"Deco","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110321_bib29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41588-018-0269-7","article-title":"Discovery of the \ufb01rst genome-wide signi\ufb01cant risk loci for attention de\ufb01cit\/hyperactivity disorder","volume":"51","author":"Demontis","year":"2019","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110321_bib30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41588-018-0269-7","article-title":"Discovery of the first genome-wide significant risk loci for attention deficit\/hyperactivity disorder","volume":"51","author":"Demontis","year":"2019","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110321_bib31","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41588-022-01285-8","article-title":"Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains","volume":"55","author":"Demontis","year":"2023","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110321_bib32","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202152803","article-title":"Molecular networks of the FOXP2 transcription factor in the brain","volume":"22","author":"den Hoed","year":"2021","journal-title":"EMBO Rep."},{"key":"10.1016\/j.neuropharm.2025.110321_bib33","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/mp.2010.73","article-title":"Genome-wide association study of conduct disorder symptomatology","volume":"16","author":"Dick","year":"2011","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110321_bib34","article-title":"Measuring excitation\u2010inhibition balance through spectral components of local \ufb01eld potentials","volume":"24","author":"Diehl","year":"2024","journal-title":"bioRxiv preprint"},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110321_bib35","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.biopsych.2009.03.019","article-title":"Psychopathy and functional magnetic resonance imaging blood oxygenation level-dependent responses to emotional faces in violent patients with schizophrenia","volume":"66","author":"Dolan","year":"2009","journal-title":"Biol. Psychiatr."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110321_bib36","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1192\/bjp.178.4.352","article-title":"J. F. W.Relationship between 5-HT function and impulsivity and aggression in male offenders with personality disorders","volume":"178","author":"Dolan","year":"2001","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110321_bib37","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1038\/s41593-020-00744-x","article-title":"Parameterizing neural power spectra into periodic and aperiodic components","volume":"23","author":"Donoghue","year":"2020","journal-title":"Nat. Neurosci."},{"issue":"7300","key":"10.1016\/j.neuropharm.2025.110321_bib38","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nature09119","article-title":"Developmental sensory experience balances cortical excitation and inhibition","volume":"465","author":"Dorrn","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2025.110321_bib39","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.neubiorev.2020.09.013","article-title":"Neurofunctional abnormalities in antisocial spectrum: a meta-analysis of fMRI studies on Five distinct neurocognitive research domains","volume":"119","author":"Dugr\u00e9","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110321_bib40","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nrgastro.2013.86","article-title":"Genetics and alcoholism","volume":"10","author":"Edenberg","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.neuropharm.2025.110321_bib41","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1111\/epi.12050","article-title":"West syndrome caused by ST3Gal-III de\ufb01ciency","volume":"54","author":"Edvardson","year":"2013","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110321_bib42","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1002\/hbm.23475","article-title":"Cortico-limbic connectivity in MAOA-L carriers is vulnerable to acute tryptophan depletion","volume":"38","author":"Eisner","year":"2017","journal-title":"Hum. Brain Mapp."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110321_bib43","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/s41467-022-29020-1","article-title":"Impaired bidirectional communication between interneurons and oligodendrocyte precursor cells affects social cognitive behavior","volume":"13","author":"Fang","year":"2022","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110321_bib44","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/cpp.448","article-title":"Childhood origins of antisocial behavior","volume":"12","author":"Farrington","year":"2005","journal-title":"Clin. Psychol. Psychother."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110321_bib45","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1037\/0012-1649.39.6.1020","article-title":"Modeling growth in boys' aggressive behavior across elementary school: links to later criminal involvement, conduct disorder, and antisocial personality disorder","volume":"39","author":"Faze Schaeffer","year":"2003","journal-title":"Dev. Psychol."},{"key":"10.1016\/j.neuropharm.2025.110321_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.109897","article-title":"Novel pharmacological targets for GABAergic dysfunction in ADHD","volume":"249","author":"Ferranti","year":"2024","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110321_bib47","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fncel.2019.00087","article-title":"Cortical GABAergic dysfunction in stress and depression: new insights for therapeutic interventions","volume":"13","author":"Foga\u00e7a","year":"2019","journal-title":"Front. Cell. Neurosci."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110321_bib48","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1038\/s41380-020-00916-y","article-title":"Inhibition of GABA interneurons in the mPFC is sufficient and necessary for rapid antidepressant responses","volume":"26","author":"Foga\u00e7a","year":"2021","journal-title":"Mol. Psychiatr."},{"issue":"45","key":"10.1016\/j.neuropharm.2025.110321_bib49","doi-asserted-by":"crossref","first-page":"34864","DOI":"10.1074\/jbc.M110.120865","article-title":"N-glycosylation at the SynCAM (synaptic cell adhesion molecule) immunoglobulin interface modulates synaptic adhesion","volume":"285","author":"Fogel","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2025.110321_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108018","article-title":"Serotonin (5-HT) neuron-specific inactivation of Cadherin-13 impacts 5-HT system formation and cognitive function","volume":"168","author":"Forero","year":"2020","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110321_bib51","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.1038\/s41467-023-41686-9","article-title":"Myelination and excitation-inhibition balance synergistically shape structure-function coupling across the human cortex","volume":"14","author":"Fotiadis","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2025.110321_bib52","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.euroneuro.2021.02.017","article-title":"Transcranial direct current stimulation in Autism Spectrum Disorder: a systematic review and meta-analysis","volume":"48","author":"Garc\u00eda-Gonz\u00e1lez","year":"2021","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.neuropharm.2025.110321_bib53","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3389\/fpsyt.2018.00579","article-title":"Epigenetics in personality disorders: today's insights","volume":"9","author":"Gescher","year":"2018","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110321_bib54","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1146\/annurev-pharmtox-032320-015420","article-title":"Novel therapeutic approach for excitatory\/inhibitory imbalance in neurodevelopmental and neurodegenerative diseases","volume":"61","author":"Ghatak","year":"2021","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2025.110321_bib55","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11920-013-0427-7","article-title":"Antisocial personality disorder: a current review","volume":"15","author":"Glenn","year":"2013","journal-title":"Curr. Psychiatr. Rep."},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110321_bib56","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.3390\/ijms22094467","article-title":"Beyond dopamine receptor antagonism: new targets for schizophrenia treatment and prevention","volume":"22","author":"Gomes","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110321_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-63036-5","article-title":"Optogenetic inhibition of the limbic corticothalamic circuit does not alter spontaneous oscillatory activity, auditory-evoked oscillations, and deviant detection","volume":"14","author":"Gonzalez-Burgos","year":"2024","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110321_bib58","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.biopsych.2023.03.026","article-title":"40-Hz auditory steady-state responses in schizophrenia: toward a mechanistic biomarker for circuit dysfunctions and early detection and diagnosis","volume":"94","author":"Grent-'t-Jong","year":"2023","journal-title":"Biol. Psychiatr."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110321_bib59","first-page":"548","volume":"54","author":"Grotzinger","year":"2022","journal-title":"Genetic architecture of 11 major psychiatric disorders at biobehavioral, functional genomic and molecular genetic levels of analysis. Nat Genet"},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110321_bib60","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1002\/glia.23618","article-title":"Glutamate versus GABA in neuron-oligodendroglia communication","volume":"67","author":"Habermacher","year":"2019","journal-title":"Glia"},{"issue":"18","key":"10.1016\/j.neuropharm.2025.110321_bib61","doi-asserted-by":"crossref","first-page":"7272","DOI":"10.1523\/JNEUROSCI.4747-14.2015","article-title":"Myelin loss and axonal ion channel adaptations associated with gray matter neuronal hyperexcitability","volume":"35","author":"Hamada","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110321_bib62","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.pediatrneurol.2016.03.010","article-title":"Recent advances in resting-state electroencephalography biomarkers for autism spectrum disorder-A review of methodological and clinical challenges","volume":"61","author":"Heunis","year":"2016","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.neuropharm.2025.110321_bib63","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ajhg.2011.08.008","article-title":"ST3GAL3 mutations impair the development of higher cognitive functions","volume":"89","author":"Hu","year":"2011","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110321_bib64","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41398-021-01480-x","article-title":"Genetic association study of childhood aggression across raters, instruments, and age","volume":"11","author":"Ip","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110321_bib65","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.neuron.2011.09.027","article-title":"How inhibition shapes cortical activity","volume":"72","author":"Isaacson","year":"2011","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110321_bib66","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/mp.2011.59","article-title":"A cooperative interaction between LPHN3 and 11q doubles the risk for ADHD","volume":"17","author":"Jain","year":"2012","journal-title":"Mol. Psychiatr."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110321_bib67","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/WCO.0000000000000181","article-title":"Electrophysiological biomarkers of diagnosis and outcome in neurodevelopmental disorders","volume":"28","author":"Jeste","year":"2015","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.neuropharm.2025.110321_bib68","article-title":"Reduced white matter integrity in antisocial personality disorder: a diffusion tensor imaging study","volume":"7","author":"Jiang","year":"2017","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110321_bib69","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/nn.3140","article-title":"A mechanism for value-guided choice based on the excitation-inhibition balance in prefrontal cortex","volume":"15","author":"Jocham","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110321_bib70","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3389\/fpsyt.2019.01027","article-title":"A systematic literature review of neuroimaging of psychopathic traits","volume":"10","author":"Johanson","year":"2020","journal-title":"Front. Psychiatr."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110321_bib71","first-page":"251","article-title":"Prediction of behavioral improvement through resting-state electroencephalography and clinical severity in a randomized controlled trial testing bumetanide in autism spectrum disorder","volume":"8","author":"Juarez-Martinez","year":"2023","journal-title":"Biol. Psychiatry Cogn. Neurosci Neuroimaging"},{"issue":"Pt B","key":"10.1016\/j.neuropharm.2025.110321_bib72","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.pnpbp.2017.06.011","article-title":"Further replication of the synergistic interaction between LPHN3 and the NTAD gene cluster on ADHD and its clinical course throughout adulthood","volume":"79","author":"Kappel","year":"2017","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110321_bib73","first-page":"CD007667","article-title":"Pharmacological interventions for antisocial personality disorder","volume":"9","author":"Khalifa","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110321_bib74","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0006-3223(01)01222-7","article-title":"Limbic abnormalities in affective processing by criminal psychopaths as revealed by functional magnetic resonance imaging","volume":"50","author":"Kiehl","year":"2001","journal-title":"Biol. Psychiatr."},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110321_bib75","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.3390\/ijms22105113","article-title":"Implications of extended inhibitory neuron development","volume":"22","author":"Kim","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110321_bib76","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/jcpp.12392","article-title":"Annual research review: the (epi)genetics of neurodevelopmental disorders in the era of whole-genome sequencing--unveiling the dark matter","volume":"56","author":"Kiser","year":"2015","journal-title":"J. Child Psychol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110321_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2020.101875","article-title":"The role of monoamine oxidase A in the neurobiology of aggressive, antisocial, and violent behavior: a tale of mice and men","volume":"194","author":"Kolla","year":"2020","journal-title":"Prog. Neurobiol."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110321_bib78","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11920-019-1011-6","article-title":"Single-Photon emission computed tomography and positron emission tomography studies of antisocial personality disorder and aggression: a targeted review","volume":"21","author":"Kolla","year":"2019","journal-title":"Curr. Psychiatr. Rep."},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110321_bib79","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/mp.2012.29","article-title":"The ADHD-susceptibility gene lphn3.1 modulates dopaminergic neuron formation and locomotor activity during zebrafish development","volume":"17","author":"Lange","year":"2012","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110321_bib80","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/jcpp.13031","article-title":"Editorial: can dysregulated myelination be linked to ADHD pathogenesis and persistence?","volume":"60","author":"Lesch","year":"2019","journal-title":"J. Child Psychol. Psychiatry Allied Discip."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110321_bib81","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/1099-0798(200010)18:5<581::AID-BSL411>3.0.CO;2-L","article-title":"Impulsivity, aggression, and serotonin: a molecular psychobiological perspective","volume":"18","author":"Lesch","year":"2000","journal-title":"Behav. Sci. Law"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110321_bib82","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neuron.2012.09.013","article-title":"Serotonin in the modulation of neural plasticity and networks: implications for neurodevelopmental disorders","volume":"76","author":"Lesch","year":"2012","journal-title":"Neuron"},{"issue":"1601","key":"10.1016\/j.neuropharm.2025.110321_bib83","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1098\/rstb.2012.0039","article-title":"Targeting brain serotonin synthesis: insights into neurodevelopmental disorders with long-term outcomes related to negative emotionality, aggression and antisocial behaviour","volume":"367","author":"Lesch","year":"2012","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110321_bib84","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.euroneuro.2012.07.013","article-title":"Dances with black widow spiders: dysregulation of glutamate signalling enters centre stage in ADHD","volume":"23","author":"Lesch","year":"2013","journal-title":"Eur. Neuropsychopharmacol"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110321_bib85","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nrn1648","article-title":"Cortical inhibitory neurons and schizophrenia","volume":"6","author":"Lewis","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110321_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107494","article-title":"A hypothesis of monoamine (5-HT) - glutamate\/GABA long neural circuit: aiming for fast-onset antidepressant discovery","volume":"208","author":"Li","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2025.110321_bib87","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neuropharm.2012.04.010","article-title":"Metabotropic glutamate 7 (mGlu7) receptor: a target for medication development for the treatment of cocaine dependence","volume":"66","author":"Li","year":"2013","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110321_bib88","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/YPG.0000000000000352","article-title":"Genome-wide association study of antisocial personality disorder diagnostic criteria provides evidence for shared risk factors across disorders","volume":"33","author":"Li","year":"2023","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.neuropharm.2025.110321_bib89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.npep.2018.09.003","article-title":"Oxytocin and excitation\/inhibition balance in social recognition","volume":"72","author":"Lopatina","year":"2018","journal-title":"Neuropeptides"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110321_bib90","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41398-021-01651-w","article-title":"Increased locomotor activity via regulation of GABAergic signalling in foxp2 mutant zebrafish-implications for neurodevelopmental disorders","volume":"11","author":"L\u00fcffe","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110321_bib91","series-title":"The Oxford Handbook of Personality Disorders","first-page":"268","article-title":"Antisocial personality disorder in youth","author":"Lynam","year":"2012"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110321_bib92","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1038\/s41467-020-16218-4","article-title":"Interneuron hypomyelination is associated with cognitive inflexibility in a rat model of schizophrenia","volume":"11","author":"Maas","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110321_bib93","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/brainsci11010091","article-title":"Precision medicine care in ADHD: the case for neural excitation and inhibition","volume":"11","author":"Mamiya","year":"2021","journal-title":"Brain Sci."},{"key":"10.1016\/j.neuropharm.2025.110321_bib94","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3389\/fncel.2016.00027","article-title":"Systematic review of pharmacological properties of the oligodendrocyte lineage","volume":"10","author":"Marinelli","year":"2016","journal-title":"Front. Cell. Neurosci."},{"issue":"7548","key":"10.1016\/j.neuropharm.2025.110321_bib95","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nature14402","article-title":"Oxytocin enables maternal behaviour by balancing cortical inhibition","volume":"520","author":"Marlin","year":"2015","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110321_bib96","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.biopsych.2016.06.026","article-title":"An ultraconserved brain-specific enhancer within ADGRL3 (LPHN3) underpins attention-deficit\/hyperactivity disorder susceptibility","volume":"80","author":"Martinez","year":"2016","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110321_bib97","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2147\/TACG.S361239","article-title":"Case report of a juvenile patient with autism spectrum disorder with a novel combination of copy number variants in ADGRL3 (LPHN3) and two pseudogenes","volume":"15","author":"Maurer","year":"2022","journal-title":"Appl. Clin. Genet."},{"key":"10.1016\/j.neuropharm.2025.110321_bib98","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1296527","article-title":"A paradoxical switch: the implications of excitatory GABAergic signaling in neurological disorders","volume":"14","author":"McArdle","year":"2024","journal-title":"Front. Psychiatr."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110321_bib99","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00406-022-01388-7","article-title":"Dissecting the cross-trait effects of the FOXP2 GWAS hit on clinical and brain phenotypes in adults with ADHD","volume":"273","author":"Meyer","year":"2023","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110321_bib100","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.15784","article-title":"A large fraction of neocortical myelin ensheathes axons of local inhibitory neurons","volume":"5","author":"Micheva","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.neuropharm.2025.110321_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneumeth.2020.108990","article-title":"Towards in vivo g-ratio mapping using MRI: unifying myelin and diffusion imaging","volume":"348","author":"Mohammadi","year":"2021","journal-title":"J. Neurosci. Methods"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110321_bib102","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/cercor\/bhp114","article-title":"Serotoninergic fine-tuning of the excitation-inhibition balance in rat visual cortical networks","volume":"20","author":"Moreau","year":"2010","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.neuropharm.2025.110321_bib103","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.neuroscience.2013.02.013","article-title":"Serotonergic modulation of LTP at excitatory and inhibitory synapses in the developing rat visual cortex","volume":"238","author":"Moreau","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2025.110321_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.02.039","article-title":"Dissociation of impulsivity and aggression in mice deficient for the ADHD risk gene Adgrl3: evidence for dopamine transporter dysregulation","volume":"156","author":"Mortimer","year":"2019","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110321_bib105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41380-021-01117-x","article-title":"Cadherin-13 is a critical regulator of GABAergic modulation in human stem-cell-derived neuronal networks","volume":"27","author":"Mossink","year":"2022","journal-title":"Mol. Psychiatr."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110321_bib106","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/ajmg.b.32317","article-title":"NCAM1-TTC12-ANKK1-DRD2 gene cluster and the clinical and genetic heterogeneity of adults with ADHD","volume":"168","author":"Mota","year":"2015","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110321_bib107","doi-asserted-by":"crossref","first-page":"e999","DOI":"10.1038\/tp.2016.273","article-title":"Glutamatergic and GABAergic gene sets in attention-deficit\/hyperactivity disorder: association to overlapping traits in ADHD and autism","volume":"7","author":"Naaijen","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110321_bib108","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1007\/s11064-013-0977-4","article-title":"Structural plasticity of interneurons in the adult brain: role of PSA-NCAM and implications for psychiatric disorders","volume":"38","author":"Nacher","year":"2013","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2025.110321_bib109","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3922\/j.psns.2014.4.20","article-title":"Aggressive behavior and three neurotransmitters: dopamine, GABA, and serotonin - a review of the last 10 years","volume":"7","author":"Narvaes","year":"2014","journal-title":"Psychol. Neurosci."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110321_bib110","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.neuron.2015.07.033","article-title":"Excitatory\/inhibitory balance and circuit homeostasis in autism spectrum disorders","volume":"87","author":"Nelson","year":"2015","journal-title":"Neuron"},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110321_bib111","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/s41593-023-01406-4","article-title":"Cortical astrocytes modulate dominance behavior in male mice by regulating synaptic excitatory and inhibitory balance","volume":"26","author":"Noh","year":"2023","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110321_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.112306","article-title":"The effects of early life stress on the excitatory\/inhibitory balance of the medial prefrontal cortex","volume":"379","author":"Ohta","year":"2020","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110321_bib113","first-page":"11","article-title":"The biology of impulsivity and suicidality","volume":"23","author":"Oquendo","year":"2000","journal-title":"Psychiatr. Clin."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110321_bib114","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1038\/s41467-019-11904-4","article-title":"Developmental cell death regulates lineage-related interneuron-oligodendroglia functional clusters and oligodendrocyte homeostasis","volume":"10","author":"Orduz","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2025.110321_bib115","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neubiorev.2019.07.024","article-title":"Prefrontal excitatory\/inhibitory balance in stress and emotional disorders: evidence for over-inhibition","volume":"105","author":"Page","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2025.110321_bib116","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.neubiorev.2021.01.024","article-title":"The postnatal GABA shift: a developmental perspective","volume":"124","author":"Peerboom","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110321_bib117","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s40263-023-01027-2","article-title":"New GABA-targeting therapies for the treatment of seizures and epilepsy: I. Role of GABA as a modulator of seizure activity and recently approved medications acting on the GABA system","volume":"37","author":"Perucca","year":"2023","journal-title":"CNS Drugs"},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110321_bib118","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1111\/cns.14283","article-title":"A preliminary transcriptomic analysis of the orbitofrontal cortex of antisocial individuals","volume":"29","author":"Piras","year":"2023","journal-title":"CNS Neurosci. Ther."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110321_bib119","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/jcpp.13782","article-title":"Genome-wide DNA methylation analysis of aggressive behaviour: a longitudinal population-based study","volume":"64","author":"Pishva","year":"2023","journal-title":"J. Child Psychol. Psychiatry"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110321_bib120","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1096\/fj.201901793R","article-title":"ST3GAL3, ST3GAL4, and ST3GAL6 differ in their regulation of biological functions via the specificities for the \u03b12,3-sialylation of target proteins","volume":"34","author":"Qi","year":"2020","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110321_bib121","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/(SICI)1099-0798(199822)16:3<319::AID-BSL311>3.0.CO;2-G","article-title":"Reduced prefrontal and increased subcortical brain functioning assessed using positron emission tomography in predatory and affective murderers","volume":"16","author":"Raine","year":"1998","journal-title":"Behav. Sci. Law"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110321_bib122","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1001\/archpsyc.57.2.119","article-title":"Reduced prefrontal gray matter volume and reduced autonomic activity in antisocial personality disorder","volume":"57","author":"Raine","year":"2000","journal-title":"Arch. Gen. Psychiatr."},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110321_bib123","doi-asserted-by":"crossref","first-page":"e883","DOI":"10.1038\/tp.2016.155","article-title":"Genome-wide association study of antisocial personality disorder","volume":"6","author":"Rautiainen","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110321_bib124","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.neubiorev.2021.04.030","article-title":"Latrophilin-3 disruption: effects on brain and behavior","volume":"127","author":"Regan","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110321_bib125","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1037\/0033-2909.128.3.490","article-title":"Genetic and environmental influences on antisocial behavior: a meta-analysis of twin and adoption studies","volume":"128","author":"Rhee","year":"2002","journal-title":"Psychol. Bull."},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110321_bib126","doi-asserted-by":"crossref","first-page":"e655","DOI":"10.1038\/tp.2015.152","article-title":"Cadherin-13, a risk gene for ADHD and comorbid disorders, impacts GABAergic function in hippocampus and cognition","volume":"5","author":"Rivero","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110321_bib127","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.688488","article-title":"Haploinsufficiency of the attention-deficit\/hyperactivity disorder risk gene St3gal3 in mice causes alterations in cognition and expression of genes involved in myelination and sialylation","volume":"12","author":"Rivero","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.neuropharm.2025.110321_bib128","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fnint.2020.00031","article-title":"A systematic review of imaging studies in the combined and inattentive subtypes of attention deficit hyperactivity disorder","volume":"14","author":"Saad","year":"2020","journal-title":"Front. Integr. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110321_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2023.148249","article-title":"Is low platelet MAO activity associated with antisocial behavior? evidence from representative samples of longitudinally observed birth cohorts","volume":"1804","author":"Sakala","year":"2023","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110321_bib130","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neubiorev.2016.06.034","article-title":"Genetic influences on conduct disorder","volume":"91","author":"Salvatore","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"13","key":"10.1016\/j.neuropharm.2025.110321_bib131","first-page":"2562","article-title":"Genome-wide association studies of impulsive personality traits (BIS-11 and UPPS-P) and drug experimentation in up to 22,861 adult research participants identify loci in the CACNA1I and CADM2 genes","volume":"39","author":"Sanchez-Roige","year":"2019","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110321_bib132","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.tips.2021.09.005","article-title":"Pharmacological tools to target NKCC1 in brain disorders","volume":"42","author":"Savardi","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110321_bib133","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41593-019-0551-8","article-title":"Somatostatin interneurons in the prefrontal cortex control affective state discrimination in mice","volume":"23","author":"Scheggia","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110321_bib134","first-page":"461","article-title":"Sialic acids","volume":"94","author":"Schnaar","year":"2014","journal-title":"Sialic Acids Brain: Gangliosides Polysialic Acid Nervous Sys. Develop. Stability, Disease. Reg. Physiol. Rev"},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110321_bib135","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.107","article-title":"Prenatal stress-induced programming of genome-wide promoter DNA methylation in 5-HTT-deficient mice","volume":"4","author":"Schraut","year":"2014","journal-title":"Transl. Psychiatry"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110321_bib136","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.biocel.2012.01.008","article-title":"PSA\u2013NCAM: synaptic functions mediated by its interactions with proteoglycans and glutamate receptors","volume":"44","author":"Senkov","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110321_bib137","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.avb.2008.06.003","article-title":"Role of serotonin and dopamine system interactions in the neurobiology of impulsive aggression and its comorbidity with other clinical disorders","volume":"13","author":"Seo","year":"2008","journal-title":"Aggress. Violent Behav."},{"key":"10.1016\/j.neuropharm.2025.110321_bib138","article-title":"Use of risk assessment instruments to predict violence and antisocial behaviour in 73 samples involving 24 827 people: systematic review and meta-analysis","volume":"345","author":"Singh","year":"2012","journal-title":"Br. Med. J."},{"key":"10.1016\/j.neuropharm.2025.110321_bib139","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.pnpbp.2019.04.002","article-title":"Differential levels of prefrontal cortex glutamate+glutamine in adults with antisocial personality disorder and bipolar disorder: a proton magnetic resonance spectroscopy study","volume":"93","author":"Smaragdi","year":"2019","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110321_bib140","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/s41380-019-0426-0","article-title":"Excitation-inhibition balance as a framework for investigating mechanisms in neuropsychiatric disorders","volume":"24","author":"Sohal","year":"2019","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110321_bib141","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.conb.2017.03.014","article-title":"Functional consequences of inhibitory plasticity: homeostasis, the excitation-inhibition balance and beyond","volume":"43","author":"Sprekeler","year":"2017","journal-title":"Curr. Opin. Neurobiol."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110321_bib142","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/YCT.0000000000000510","article-title":"Physiology of transcranial direct current stimulation","volume":"34","author":"Stagg","year":"2018","journal-title":"J. ECT"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110321_bib143","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/mp.2016.147","article-title":"Myelination of parvalbumin interneurons: a parsimonious locus of pathophysiological convergence in schizophrenia","volume":"22","author":"Stedehouder","year":"2017","journal-title":"Mol. Psychiatr."},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110321_bib144","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1177\/1087054713512150","article-title":"The association between ADHD and antisocial personality disorder (ASPD): a review","volume":"20","author":"Storeb\u00f8","year":"2016","journal-title":"J. Atten. Disord."},{"key":"10.1016\/j.neuropharm.2025.110321_bib145","series-title":"The Role of Neurotransmitters in Violence and Aggression","first-page":"1","author":"Sturmey","year":"2017"},{"issue":"7300","key":"10.1016\/j.neuropharm.2025.110321_bib146","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/nature09079","article-title":"Fine-tuning of pre-balanced excitation and inhibition during auditory cortical development","volume":"465","author":"Sun","year":"2010","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110321_bib147","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cortex.2011.06.005","article-title":"White matter microstructural abnormalities in the frontal lobe of adults with antisocial personality disorder","volume":"48","author":"Sundram","year":"2012","journal-title":"Cortex"},{"issue":"35","key":"10.1016\/j.neuropharm.2025.110321_bib148","doi-asserted-by":"crossref","first-page":"12165","DOI":"10.1523\/JNEUROSCI.1181-12.2012","article-title":"Selective functional interactions between excitatory and inhibitory cortical neurons and differential contribution to persistent activity of the slow oscillation","volume":"32","author":"Tahvildari","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110321_bib149","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/7854_2011_191","article-title":"Behavioral and pharmacogenetics of aggressive behavior","volume":"12","author":"Takahashi","year":"2012","journal-title":"Curr. Top Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110321_bib150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-0-444-63327-9.00001-1","article-title":"Balancing plasticity\/stability across brain development","volume":"207","author":"Takesian","year":"2013","journal-title":"Prog. Brain Res."},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110321_bib151","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045086","article-title":"Unraveling the genetic etiology of adult antisocial behavior: a genome-wide association study","volume":"7","author":"Tielbeek","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110321_bib152","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1001\/jamapsychiatry.2017.3069","article-title":"Genome-wide association studies of a broad spectrum of antisocial behavior","volume":"74","author":"Tielbeek","year":"2017","journal-title":"JAMA Psychiatr."},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110321_bib153","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1038\/s41380-022-01793-3","article-title":"Uncovering the genetic architecture of broad antisocial behavior through a genome-wide association study meta-analysis","volume":"27","author":"Tielbeek","year":"2022","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110321_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105049","article-title":"Association between childhood maltreatment and callous-unemotional traits in youth: a meta-analysis","volume":"146","author":"Todorov","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2025.110321_bib155","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1001\/archpsyc.58.6.590","article-title":"The prevalence of personality disorders in a community sample","volume":"58","author":"Torgersen","year":"2001","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110321_bib156","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-024-02437-4","article-title":"Impaired striatal glutamate\/GABA regulation in violent offenders with antisocial personality disorder and psychopathy","author":"Tully","year":"2024","journal-title":"Mol. Psychiatr."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110321_bib157","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/nbm.3253","article-title":"In vivo quantitative magnetization transfer imaging correlates with histology during de- and remyelination in cuprizone-treated mice","volume":"28","author":"Turati","year":"2015","journal-title":"NMR Biomed."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110321_bib158","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrn1327","article-title":"Homeostatic plasticity in the developing nervous system","volume":"5","author":"Turrigiano","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110321_bib159","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s10803-022-05841-3","article-title":"Effects of Bumetanide on neurocognitive functioning in children with autism spectrum disorder: secondary analysis of a randomized placebo-controlled trial","volume":"54","author":"van Andel","year":"2024","journal-title":"J. Autism Dev. Disord."},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110321_bib160","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1111\/epi.17651","article-title":"Excitatory\/inhibitory balance in epilepsies and neurodevelopmental disorders: depolarizing \u03b3-aminobutyric acid as a common mechanism","volume":"64","author":"van Hugte","year":"2023","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2025.110321_bib161","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.nicl.2017.01.014","article-title":"White-matter tract abnormalities and antisocial behavior: a systematic review of diffusion tensor imaging studies across development","volume":"14","author":"Waller","year":"2017","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.neuropharm.2025.110321_bib162","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/mp.2016.85","article-title":"Epigenetic pro\ufb01ling of ADHD symptoms trajectories: a prospective, methylome-wide study","volume":"22","author":"Walton","year":"2017","journal-title":"Mol. Psychiatr."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110321_bib163","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.scr.2015.03.001","article-title":"Polysialic acid modification of the synaptic cell adhesion molecule SynCAM 1 in human embryonic stem cell-derived oligodendrocyte precursor cells","volume":"14","author":"Werneburg","year":"2015","journal-title":"Stem Cell Res."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110321_bib164","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3928\/00485713-20150401-08","article-title":"Epidemiology, comorbidity, and behavioral genetics of antisocial personality disorder and psychopathy","volume":"45","author":"Werner","year":"2015","journal-title":"Psychiatr. Ann."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110321_bib165","first-page":"497","article-title":"Transcranial direct current stimulation (tDCS) combined with cognitive training in adolescent boys with ADHD: a double-blind, randomised, sham-controlled trial","volume":"53","author":"Westwood","year":"2023","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neuropharm.2025.110321_bib166","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/bs.apha.2020.05.001","article-title":"Effects of ketamine and other rapidly acting antidepressants on hippocampal excitatory and inhibitory transmission","volume":"89","author":"Widman","year":"2020","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110321_bib167","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2021.631838","article-title":"Neurobiological mechanisms of transcranial direct current stimulation for psychiatric disorders; neurophysiological, chemical, and anatomical considerations","volume":"15","author":"Yamada","year":"2021","journal-title":"Front. Hum. Neurosci."},{"issue":"6523","key":"10.1016\/j.neuropharm.2025.110321_bib168","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd2109","article-title":"Neuron class-specific responses govern adaptive myelin remodeling in the neocortex","volume":"370","author":"Yang","year":"2020","journal-title":"Science"},{"issue":"7363","key":"10.1016\/j.neuropharm.2025.110321_bib169","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nature10360","article-title":"Neocortical excitation\/inhibition balance in information processing and social dysfunction","volume":"477","author":"Yizhar","year":"2011","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110321_bib170","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1096\/fj.15-270983","article-title":"Sialylation regulates brain structure and function","volume":"29","author":"Yoo","year":"2015","journal-title":"FASEB J"},{"issue":"23","key":"10.1016\/j.neuropharm.2025.110321_bib171","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2318641121","article-title":"In vivo whole-cortex marker of excitation-inhibition ratio indexes cortical maturation and cognitive ability in youth","volume":"121","author":"Zhang","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110321_bib172","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/s41593-019-0394-3","article-title":"Compulsivity and impulsivity traits linked to attenuated developmental frontostriatal myelination trajectories","volume":"22","author":"Ziegler","year":"2019","journal-title":"Nat. Neurosci."},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110321_bib173","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1016\/j.celrep.2019.05.018","article-title":"Individual oligodendrocytes show bias for inhibitory axons in the neocortex","volume":"27","author":"Zonouzi","year":"2019","journal-title":"Cell Rep."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825000279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825000279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:59:04Z","timestamp":1762214344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825000279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":173,"alternative-id":["S0028390825000279"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110321","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antisocial personality disorder:Failure to balance excitation\/inhibition?","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110321","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110321"}}